Blood cholesterol regulation (None (as this is not a single molecule or protein).)

Blood cholesterol regulation refers broadly to the physiological processes that maintain appropriate levels and distribution of various forms of circulating cholesterols—primarily through coordinated actions involving hepatic uptake by low-density lipoprotein receptors; endogenous synthesis regulated by enzymes such as HMG-CoA reductase; transcriptional control mediated by sterol regulatory element-binding proteins; intestinal absorption through transporters like NPC1L1; and reverse transport mechanisms facilitated by high-density lipoproteins. Disruption in any component can lead to abnormal plasma lipid profiles associated with increased cardiovascular risk. Therapeutic interventions typically focus on one or more key nodes within these networks—most notably the LDL receptor pathway—to lower harmful LDL-cholesterol concentrations in patients at risk for cardiovascular events[2][5][4][3].

Other names

Cholesterol homeostasisCholesterol metabolismRegulation of plasma cholesterol

Mechanisms for drugs targeting components of this pathway include: – Inhibition of de novo synthesis via HMG-CoA reductase inhibition – Blockade of intestinal absorption via NPC1L1 inhibition – Prevention of LDL receptor degradation via PCSK9 inhibition